"Tech is not good or bad, but neither is it neutral." -- Mishal Khan, PhD, of the UC Berkeley Labor Center in California, on ...

(Traditional Medicare has increasingly come to resemble private insurance with premiums and coinsurance, and, unlike standard ...

When I led the military health system, I was asked to help a service member whose family had been transferred to a military ...

The FDA approved veligrotug (Lumvoa) for the treatment of thyroid eye disease (TED), regardless of disease activity or duration, Viridian Therapeutics announced on Friday. Veligrotug is the first ...

The FDA approved satralizumab (Enspryng), the first and only at-home subcutaneous treatment option for adults with thyroid eye disease (TED), developer Roche announced on Thursday.

Two decades ago, makeover shows dominated reality TV, but one show took it further than the rest. Now, in a new documentary, ...

Subcutaneous risankizumab (Skyrizi) induction therapy significantly improved clinical remission and endoscopic response rates ...

Caused by extraintestinal pathogenic E. coli, a common cause of UTIs and bloodstream infections, IED is an acute illness that ...

Investments in pharmaceutical companies made on behalf of President Donald Trump increased significantly after he returned to ...

Hemodynamic instability in septic shock and surgical stress may compromise tissue perfusion and lead to acute kidney injury ...

The FDA announced approval of apraclonidine ophthalmic solution 0.125% (Brytly) as an over-the-counter treatment for eye ...

A 2022 paper that found COVID-19 vaccination elicits broad neutralizing antibodies in mice was retracted by Science ...